Prof. El Aidy wins Gut Microbiome Therapeutic Innovation challenge
Prof. Sahar El Aidy from the Groningen Biomolecular Sciences and Biotechnology Institute ( GBB ) has won the ProDigest and CosmosID Gut Microbiome Therapeutic Innovation ( GMTI ) challenge out of almost fifty submissions from all over the world. Prof. El Aidy won the challenge with her research plan to investigate the ‘Role of anti-Parkinson’s Disease (PD) medication in enhancing bacterial overgrowth and community dynamics along the gastrointestinal tract’. She receives EUR 50,000 to conduct her project on ProDigest’s gastrointestinal SHIME® platform, an in vitro simulator of the gastrointestinal tract.
The aim of the project is to identify which gut bacterial metabolites can improve or impair communication with the host gut-brain axis and effectiveness of drug treatments. According to the reviewing committee, the project of Prof. El Aidy ‘addresses the growing question of the role of the microbiota in the Parkinson’s Disease and of drug-bugs interactions’.
Last modified: | 23 May 2025 08.43 a.m. |
More news
-
25 July 2025
Article highlight: New insight in how cells regulate gene activity
A new study, led by University of Groningen molecular biologist Danny Incarnato, identifies hundreds of shapeshifting regulatory RNA switches in E.coli bacteria and human cells.
-
23 July 2025
Dutch astronomers in Tenerife to test high-speed camera
Astronomers from the University of Groningen and the University of Amsterdam are on the Canary Island of Tenerife until 29 July to test a special camera to detect gamma rays emitted by extreme objects, such as supermassive black holes and supernovae....
-
17 July 2025
Veni-grants for eleven UG researchers
The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to eleven researchers of the University of Groningen and the UMCG: Quentin Changeat, Wen Wu, Femke Cnossen, Stacey Copeland, Bart Danon, Gesa Kübek, Hannah Laurens, Adi...